Vertically Integrated Cannabis Company With Products In 280 California Dispensaries And Joint Ventures, Licensing Agreement & Partnerships With Global Brands

Q4 2020 Performance Includes CDN $14.93 Million in Revenue With an Estimated CDN $5.53 Million in EBITDA a YoY Revenue Increase of 3215% from Q4 2019

Sponsored
Message: TRADING ALERT: Hollister Biosciences (HOLL:CSE) (HSTRF: OTC) Up 18% On 703K Shares

TRADING ALERT!

Last: $0.33 Change: $0.05

Percentage: 18% Volume: 703K Shares

Hub On AGORACOM

Share
New Message
Please login to post a reply